Literature DB >> 26260763

Therapy. Optimized treatment algorithms for digital vasculopathy in SSc.

Maurizio Cutolo1, Alberto Sulli1.   

Abstract

Early identification of secondary Raynaud phenomenon is essential to treat the underlying disease—most frequently systemic sclerosis (SSc). Integrated therapeutic approaches and monitoring systems that offer improved modalities of care feature in the new best practice recommendations for the treatment of digital vasculopathy in SSc.

Entities:  

Mesh：

Year:  2015        PMID： 26260763     DOI： 10.1038/nrrheum.2015.111

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.

Authors:  Maurizio Cutolo; Carmen Pizzorni; Alberto Sulli
Journal:  Arthritis Rheum       Date:  2007-06

2.  Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Authors:  Vanessa Smith; Valeria Riccieri; Carmen Pizzorni; Saskia Decuman; Ellen Deschepper; Carolien Bonroy; Alberto Sulli; Yves Piette; Filip De Keyser; Maurizio Cutolo
Journal:  J Rheumatol       Date:  2013-10-15       Impact factor: 4.666

3.  Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Authors:  J H Korn; M Mayes; M Matucci Cerinic; M Rainisio; J Pope; E Hachulla; E Rich; P Carpentier; J Molitor; J R Seibold; V Hsu; L Guillevin; S Chatterjee; H H Peter; J Coppock; A Herrick; P A Merkel; R Simms; C P Denton; D Furst; N Nguyen; M Gaitonde; Carol Black
Journal:  Arthritis Rheum       Date:  2004-12

4.  Disease modification in systemic sclerosis. Do integrated approaches offer new challenges?

Authors:  M Cutolo
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

Review 5.  Targeted immunotherapies in systemic sclerosis.

Authors:  Jérôme Avouac; Yannick Allanore
Journal:  Clin Exp Rheumatol       Date:  2014-04-15       Impact factor: 4.473

Review 6.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

Review 7.  Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.

Authors:  Michael Hughes; Voon H Ong; Marina E Anderson; Frances Hall; Pia Moinzadeh; Bridget Griffiths; Eileen Baildam; Christopher P Denton; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2015-06-26       Impact factor: 7.580

8.  Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.

Authors:  Maurizio Cutolo; Barbara Ruaro; Carmen Pizzorni; Francesca Ravera; Vanessa Smith; Giuseppe Zampogna; Sabrina Paolino; Bruno Seriolo; Marco Cimmino; Alberto Sulli
Journal:  J Rheumatol       Date:  2014-04-01       Impact factor: 4.666

9.  Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.

Authors:  Paul J Nietert; Stephanie R Shaftman; Richard M Silver; Bethany J Wolf; Brent M Egan; Kelly J Hunt; Edwin A Smith
Journal:  Clin Epidemiol       Date:  2015-02-03       Impact factor: 4.790

Review 10.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692
  10 in total
  7 in total

Review 1.  Points to consider-Raynaud's phenomenon in systemic sclerosis.

Authors:  Maurizio Cutolo; Vanessa Smith; Daniel E Furst; Dinesh Khanna; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

2.  Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology.

Authors:  Carmen Pizzorni; Alberto Sulli; Vanessa Smith; Barbara Ruaro; Amelia Chiara Trombetta; Maurizio Cutolo; Sabrina Paolino
Journal:  Clin Rheumatol       Date:  2016-10-08       Impact factor: 2.980

Review 3.  Advances in nailfold capillaroscopic analysis in systemic sclerosis.

Authors:  Barbara Ruaro; Alberto Sulli; Vanessa Smith; Carmen Pizzorni; Sabrina Paolino; Elisa Alessandri; Amelia Chiara Trombetta; Maurizio Cutolo
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09

4.  Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Authors:  Stefano Soldano; Carmen Pizzorni; Sabrina Paolino; Amelia Chiara Trombetta; Paola Montagna; Renata Brizzolara; Barbara Ruaro; Alberto Sulli; Maurizio Cutolo
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis.

Authors:  A Sulli; B Ruaro; V Smith; S Paolino; C Pizzorni; G Pesce; M Cutolo
Journal:  Arthritis Res Ther       Date:  2017-03-20       Impact factor: 5.156

6.  Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon.

Authors:  Barbara Ruaro; Vanessa Smith; Alberto Sulli; Carmen Pizzorni; Samuele Tardito; Massimo Patané; Sabrina Paolino; Maurizio Cutolo
Journal:  Front Pharmacol       Date:  2019-04-16       Impact factor: 5.810

7.  Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.

Authors:  Claudio Corallo; Maurizio Cutolo; Bashar Kahaleh; Gianluca Pecetti; Antonio Montella; Chiara Chirico; Stefano Soldano; Ranuccio Nuti; Nicola Giordano
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.